期刊
CELLULAR AND MOLECULAR LIFE SCIENCES
卷 78, 期 2, 页码 447-467出版社
SPRINGER BASEL AG
DOI: 10.1007/s00018-020-03600-0
关键词
Regenerative medicine; Aging diseases; Diabetes; Lupus; Secretome; Conditioned medium; Extracellular vesicles; Exosomes
资金
- Instituto de Salud Carlos III [PI17/02236]
- European Union (ERDF/ESF, Investing in your future)
Studies have shown that mesenchymal stem cells (MSC) have therapeutic potential in various organs and tissues. However, their functional heterogeneity poses a challenge in transferring their capabilities to clinical applications. Proper selection of MSC based on their functional potential and improving their features in the artificial niche are essential for personalized and precise medicine.
Mesenchymal stem cells (MSC) are present in all organs and tissues. Several studies have shown the therapeutic potential effect of MSC or their derived products. However, the functional heterogeneity of MSC constitutes an important barrier for transferring these capabilities to the clinic. MSC heterogeneity depends on their origin (biological niche) or the conditions of potential donors (age, diseases or unknown factors). It is accepted that many culture conditions of the artificial niche to which they are subjected, such as O(2)tension, substrate and extracellular matrix cues, inflammatory stimuli or genetic manipulations can influence their resulting phenotype. Therefore, to attain a more personalized and precise medicine, a correct selection of MSC is mandatory, based on their functional potential, as well as the need to integrate all the existing information to achieve an optimal improvement of MSC features in the artificial niche.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据